Literature DB >> 23726802

Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects.

Kei Takahashi1, Shin-Ichi Yokota, Naoyuki Tatsumi, Tatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima.   

Abstract

Circulating microRNAs (miRNAs) are receiving attention as potential biomarkers of various diseases, including cancers, chronic obstructive pulmonary disease, and cardiovascular disease. However, it is unknown whether the levels of circulating miRNAs in a healthy subject might vary with external factors in daily life. In this study, we investigated whether cigarette smoking, a habit that has spread throughout the world and is a risk factor for various diseases, affects plasma miRNA profiles. We determined the profiles of 11 smokers and 7 non-smokers by TaqMan MicroRNA array analysis. A larger number of miRNAs were detected in smokers than in non-smokers, and the plasma levels of two-thirds of the detected miRNAs (43 miRNAs) were significantly higher in smokers than in non-smokers. A principal component analysis of the plasma miRNA profiles clearly separated smokers and non-smokers. Twenty-four of the miRNAs were previously reported to be potential biomarkers of disease, suggesting the possibility that smoking status might interfere with the diagnosis of disease. Interestingly, we found that quitting smoking altered the plasma miRNA profiles to resemble those of non-smokers. These results suggested that the differences in the plasma miRNA profiles between smokers and non-smokers could be attributed to cigarette smoking. In addition, we found that an acute exposure of ex-smokers to cigarette smoke (smoking one cigarette) did not cause a dramatic change in the plasma miRNA profile. In conclusion, we found that repeated cigarette smoking substantially alters the plasma miRNA profile, interfering with the diagnosis of disease or signaling potential smoking-related diseases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; MicroRNA; Smoking

Mesh:

Substances:

Year:  2013        PMID: 23726802     DOI: 10.1016/j.taap.2013.05.018

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  44 in total

Review 1.  Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma.

Authors:  Michela Bottani; Giuseppe Banfi; Giovanni Lombardi
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 2.  Circulating microRNAs and diabetes: potential applications in medical practice.

Authors:  Juliette Raffort; Charlotte Hinault; Olivier Dumortier; Emmanuel Van Obberghen
Journal:  Diabetologia       Date:  2015-07-09       Impact factor: 10.122

3.  Spring is in the air: seasonal profiles indicate vernal change of miRNA activity.

Authors:  Nicole Ludwig; Anne Hecksteden; Mustafa Kahraman; Tobias Fehlmann; Thomas Laufer; Fabian Kern; Tim Meyer; Eckart Meese; Andreas Keller; Christina Backes
Journal:  RNA Biol       Date:  2019-05-10       Impact factor: 4.652

Review 4.  Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.

Authors:  Blanca Ortiz-Quintero
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

Review 5.  MicroRNAs regulate synaptic plasticity underlying drug addiction.

Authors:  A C W Smith; P J Kenny
Journal:  Genes Brain Behav       Date:  2017-10-10       Impact factor: 3.449

6.  MicroRNA Signature of Cigarette Smoking and Evidence for a Putative Causal Role of MicroRNAs in Smoking-Related Inflammation and Target Organ Damage.

Authors:  Christine M Willinger; Jian Rong; Kahraman Tanriverdi; Paul L Courchesne; Tianxiao Huan; Gregory A Wasserman; Honghuang Lin; Josée Dupuis; Roby Joehanes; Matthew R Jones; George Chen; Emelia J Benjamin; George T O'Connor; Joseph P Mizgerd; Jane E Freedman; Martin G Larson; Daniel Levy
Journal:  Circ Cardiovasc Genet       Date:  2017-10

7.  Machine Learning Approach for Predicting Past Environmental Exposures From Molecular Profiling of Post-Exposure Human Serum Samples.

Authors:  Atif Khan; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps; Philip K Hopke; Mark J Utell; Pamela L Krahl; Timothy M Mallon; Juilee Thakar
Journal:  J Occup Environ Med       Date:  2019-12       Impact factor: 2.162

Review 8.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

Review 9.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

Review 10.  Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.

Authors:  Viswam S Nair; Colin C Pritchard; Muneesh Tewari; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.